Annette Schmidt

Prof. Dr. Annette Schmidt

Institute for Sports Science, Faculty of Human Sciences, University of the Federal Armed Forces Munich, 85579 Neubiberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Sports
Verified
Journal Article
Open access
PDF file
NMNicole Meier
Nicole Meier
Jennifer SchlieJennifer Schlie
Jennifer Schlie
Annette SchmidtAnnette Schmidt
Annette Schmidt
The functional fitness training program CrossFit® is experiencing fast-growing and widespread popularity with day-to-day varying ‘Workouts of the Day’ (WOD). Even among tactical athletes, the training program is widely applied. Nevertheless, there is a lack of data on which parameters influence CrossFit® performance. For this reason, the purpose of this study is to conduct a systematic review of the existing literature to identify and summarize predictors of CrossFit® performance and performance enhancement. In accordance with the PRISMA guidelines, a systematic search of the following databases was conducted in April 2022: PubMed, SPORTDiscus, Scopus, and Web of Science. Using the keyword ‘CrossFit’, 1264 entries are found, and 21 articles are included based on the eligibility criteria. In summary, the studies show conflicting results, and no specific key parameter was found that predicts CrossFit® performance regardless of the type of WOD. In detail, the findings indicate that physiological parameters (in particular, body composition) and high-level competitive experience have a more consistent influence than specific performance variables. Nevertheless, in one-third of the studies, high total body strength (i.e., CrossFit® Total performance) and trunk strength (i.e., back squat performance) correlate with higher workout scores. For the first time, this review presents a summary of performance determinants in CrossFit®. From this, a guiding principle for training strategies may be derived, suggesting that a focus on body composition, body strength, and competition experience may be recommended for CrossFit® performance prediction and performance enhancement.

1 September 2025 in Journal of Applied Physiology
Verified
Journal Article
Closed access
Jennifer SchlieJennifer Schlie
Jennifer Schlie
VKVivien Krassowski
Vivien Krassowski
Annette SchmidtAnnette Schmidt
Annette Schmidt
Whether different menstrual cycle (MC) phases are associated with differences in athletic performance is a constant scientific debate. Phase verification without actual sex hormone determination and heterogeneous cohorts complicates the analysis. Therefore, this review only includes studies in which 17β-estradiol, progesterone, and luteinizing hormone were measured. The aim was to assess the prevalence of these methodological standards and determine the representativeness of elite athletes. Furthermore, the associations between the MC phase and athletic performance were analyzed. Four databases were searched for studies investigating athletic performance and performance-related outcomes in ≥2 phases in eumenorrheic females. Nineteen studies (total n = 279, 25.6 ± 3.6 yr, mean sample size n = 13.9 ± 7) were included, with elite athletes underrepresented. Most compared the three phases; particularly, the early follicular (EF) phase was used. Fifty-eight percent reported significant phase effects on at least one performance-related outcome, although the direction and magnitude varied between studies. The EF was identified as unfavorable for V̇o2max by one study and for peak power by two studies. Submaximal ventilation was reduced during the EF. Maximum and explosive strength remained largely unaffected. Neuromuscular coordination was improved during ovulation. A medium to high risk of bias was identified in the randomization and reported outcomes. Despite focusing on studies with high methodological standards, the heterogeneity of phases and populations studied complicates a systematic analysis. The prevalence of serum hormone analysis in elite sports appeared to be poor. The risk of bias suggests to critically approach conclusions about the presence or absence of MC effects.

1 October 2005 in European Journal of Cell Biology
Verified
Journal Article
Closed access
FKFranz-Josef Klinz
Franz-Josef Klinz
Annette SchmidtAnnette Schmidt
Annette Schmidt
TSTimo Schinköthe
Timo Schinköthe
Stefan ArnholdStefan Arnhold
Stefan Arnhold
BDBiren Desai
Biren Desai
WBWilhelm Bloch
Wilhelm Bloch

23 November 2023 in JMIR Cardio
Verified
Journal Article
Open access
KKKristina Klier
Kristina Klier
LKLucas Koch
Lucas Koch
LGLisa Graf
Lisa Graf
TSTimo Schinköthe
Timo Schinköthe
Annette SchmidtAnnette Schmidt
Annette Schmidt
Background: To date, the 12-lead electrocardiogram (ECG) is the gold standard for cardiological diagnosis in clinical settings. With the advancements in technology, a growing number of smartphone apps and gadgets for recording, visualizing, and evaluating physical performance as well as health data is available. Although this new smart technology is innovative and time- and cost-efficient, less is known about its diagnostic accuracy and reliability. Objective: This study aimed to examine the agreement between the mobile single-lead ECG measurements of the Kardia Mobile App and the Apple Watch 4 compared to the 12-lead gold standard ECG in healthy adults under laboratory conditions. Furthermore, it assessed whether the measurement error of the devices increases with an increasing heart rate. Methods: This study was designed as a prospective quasi-experimental 1-sample measurement, in which no randomization of the sampling was carried out. In total, ECGs at rest from 81 participants (average age 24.89, SD 8.58 years; n=58, 72% male) were recorded and statistically analyzed. Bland-Altman plots were created to graphically illustrate measurement differences. To analyze the agreement between the single-lead ECGs and the 12-lead ECG, Pearson correlation coefficient (r) and Lin concordance correlation coefficient (CCCLin) were calculated. Results: The results showed a higher agreement for the Apple Watch (mean deviation QT: 6.85%; QT interval corrected for heart rate using Fridericia formula [QTcF]: 7.43%) than Kardia Mobile (mean deviation QT: 9.53%; QTcF: 9.78%) even if both tend to underestimate QT and QTcF intervals. For Kardia Mobile, the QT and QTcF intervals correlated significantly with the gold standard (rQT=0.857 and rQTcF=0.727; P<.001). CCCLin corresponded to an almost complete heuristic agreement for the QT interval (0.835), whereas the QTcF interval was in the range of strong agreement (0.682). Further, for the Apple Watch, Pearson correlations were highly significant and in the range of a large effect (rQT=0.793 and rQTcF=0.649; P<.001). CCCLin corresponded to a strong heuristic agreement for both the QT (0.779) and QTcF (0.615) intervals. A small negative correlation between the measurement error and increasing heart rate could be found of each the devices and the reference. Conclusions: Smart technology seems to be a promising and reliable approach for nonclinical health monitoring. Further research is needed to broaden the evidence regarding its validity and usability in different target groups.

2 June 2021 in Sports
Verified
Journal Article
Open access
PDF file
NMNicole Meier
Nicole Meier
SRStefan Rabel
Stefan Rabel
Annette SchmidtAnnette Schmidt
Annette Schmidt
In the trend sport CrossFit®, international competition is held at the CrossFit® Games, known worldwide as the definitive fitness test. Since American athletes are the best in the world regarding CrossFit®, there might be influencing factors on international competition performance. Here, we characterize the benchmark performance profile of American and German CrossFit® athletes (n = 162). To collect the common benchmark performance by questionnaire, 66 male and 96 female CrossFit® athletes (32.6 ± 8.2 years) participated in our survey in both nations. By comparing the individual performance variables, only a significant difference in total power lift performance by males was identified between the nations (p = 0.034). No other significant differences were found in the Olympic lift, running, or the “Girl” Workout of the Day (Fran, Grace, Helen) performance. Very large to extremely large (r = 0.79–0.99, p < 0.01) positive correlations were found between the power lift and Olympic lift variables. Further linear regression analysis predicted the influence of back squat performance on performance in the Olympic lifts, snatch (R2 = 0.76) and clean and jerk (R2 = 0.84). Our results suggested a dominant role of back squat performance in the assessment of physical fitness of CrossFit® athletes.

5 September 2024 in Sensors
Verified
Journal Article
Open access
PDF file
EFEva Fellinger
Eva Fellinger
TBTom Brandt
Tom Brandt
JCJustin Creutzburg
Justin Creutzburg
TRTessa Rommerskirchen
Tessa Rommerskirchen
Annette SchmidtAnnette Schmidt
Annette Schmidt
Continuous Glucose Monitoring (CGM) not only can be used for glycemic control in chronic diseases (e.g., diabetes), but is increasingly being utilized by individuals and athletes to monitor fluctuations in training and everyday life. However, it is not clear how accurately CGM reflects plasma glucose concentration in a healthy population in the absence of chronic diseases. In an oral glucose tolerance test (OGTT) with forty-four healthy male subjects (25.5 ± 4.5 years), the interstitial fluid glucose (ISFG) concentration obtained by a CGM sensor was compared against finger-prick capillary plasma glucose (CPG) concentration at fasting baseline (T0) and 30 (T30), 60 (T60), 90 (T90), and 120 (T120) min post OGTT to investigate differences in measurement accuracy. The overall mean absolute relative difference (MARD) was 12.9% (95%-CI: 11.8–14.0%). Approximately 100% of the ISFG values were within zones A and B in the Consensus Error Grid, indicating clinical accuracy. A paired t-test revealed statistically significant differences between CPG and ISFG at all time points (T0: 97.3 mg/dL vs. 89.7 mg/dL, T30: 159.9 mg/dL vs. 144.3 mg/dL, T60: 134.8 mg/dL vs. 126.2 mg/dL, T90: 113.7 mg/dL vs. 99.3 mg/dL, and T120: 91.8 mg/dL vs. 82.6 mg/dL; p < 0.001) with medium to large effect sizes (d = 0.57–1.02) and with ISFG systematically under-reporting the reference system CPG. CGM sensors provide a convenient and reliable method for monitoring blood glucose in the everyday lives of healthy adults. Nonetheless, their use in clinical settings wherein implications are drawn from CGM readings should be handled carefully.